FDA Investigator Vilmary Negron Rodriguez

Vilmary Negron Rodriguez has inspections in 15 countries as of 23 Oct 2023. Vilmary Negron Rodriguez has collaborated with a combinined 5205 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
62
Last Inspection Date:
23 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
Hungary, India, Japan, Israel, United States of America, Spain, France, United Kingdom of Great Britain and Northern Ireland, Mexico, Germany, China, Croatia, Switzerland, Poland
Co-Investigator(s):
Abby E Pelletier, Adaliz Santaliz Cruz, Adetutu M Gidado, Agnes M Santori, Alan A Rivera, Alicia M Mozzachio, Ana M Rivera, Ana P Pineda Zavaleta, Anastasia M Shields, Andrea George, PhD, Angela E Glenn, Angelica M Hernandez, Anita Narula, PhD, Ann L Demarco, Anna Lazar, Anne L Aberdeen, Annette Melendez, Anthony E Keller, RPh, Ariel Cruz Figueroa, Arlene M Badillo, Arsen Karapetyan, Arwa S El Hagrasy, Ashar P Parikh, Ashley N Queen, PhD, Azza Talaat, Barbara J Rincon, Barbara Janine Breithaupt, Binh T Nguyen, Bo Chi, PhD, Brenda Rivera, Brooke K Higgins, Calvin B Koerner, Carl A Huffman, III, Carla J Lundi, Carlos A Medina, Carpios, Cassandra L Abellard, CDR Ileana Barreto Pettit, Charisse K Green, Charles R Cote, RIC, Cheryl A Clausen, Christina Capacci Daniel, PhD, Christopher D Rush, Christopher Downey, PhD, Christopher T Middendorf, Colleen Thomas, PhD, Cynthia J Lee, MS, Daniel J Roberts, Daniel W Cline, Darla J Christopher, David G Eng, Dayna I Martinez, Debra I Love, Demitria J Xiradakis, Denise M Digiulio, Dennis Cantellops Paite, Djamila Harouaka, Doan T Nguyen, PharmD, Donald C Obenhuber, PhD, Dongping Dai, PhD, Donna Christner, Douglas A Campbell, Douglas C Kovacs, Dov Pluznik, PhD, Dr. Barbara D Paul, PhD, Dr. Carmelo Rosa, Dr. Robert C Horan, MD, Edmund F Mrak, Jr, Edwin Martinez, Eileen A Liu, Eliezar Ramos, Ellen C Weisensel, Enrique Galan, Erika E Englund, PhD, Erika V Butler, Eva I Merced Medina, Farhana Khan, Felix Maldonado, Frances L Dejesus, Francis A Guidry, Frederick Razzaghi, Gam S Zamil, Gavin T Cua, German Rivera, Grant, Guerlain Ulysse, Helen B Ricalde, Iraida Ortiz, Ivis L Negron, Ivis Lnegron Torres, Jacob G Lutz, Jaime E Pares, James L Dunnie, Jr, James Norman, Jeffery A Hangartner, Jeffrey A Sommers, Jennifer Lalama, Jerri Baker, Joan Cantellops Figueroa, Joan M Cantellops Figueroa, Jodi M Gatica, Jorge E Martinez, Jorge L Guadalupe, Jorge L Lajara, Jose A Cruz, Jose A Lopez, Jose A Moreno, Jose Acruz Gonzalez, Jose Alopez Rubet, José E Meléndez, Jose E Melendez, DDC, Jose F Pedro, Jose Fpedrode Jesus, Jose M Cayuela, Jose Martinez, Jr, Jose Melendez, Jose R Hernandez, Jose R Lopez, Jose Rflores Veguilla, Jose Rflores Vequilla, Jose Velez, June P Page, Junho Pak, Justin A Boyd, Katherine Szestypalow, Katherine Vargas Serrano, Kejun Cheng, Kellia N Hicks, Kenneth H Williams, Kevin P Foley, Kim Lthomas Cruse, Krishna Ghosh, PhD, Kumar G Janoria, Laiza V Garcia, Lareese K Thomas, Laura E Garcia, Laurimer Kuilan, Laurimer Kuilan Torres, Leslie A Mendoza, Liatte Kreuger, PharmD, Libia M Lugo, Linda F Murphy, Lisa M Lopez, Lizaida E Rodriguez, Loreily Figueroa, Loreily Figueroa Agrinsoni, Lourdes Andujar, LT Luis O Rodriguez, LT Rafael Gonzalez, Lucila B Nwatu, Luella J Rossi, Luis A Dasta, Luis M Burgos Medero, Lynda L Perry, PhD, Margarita Santiago, Maria Gutierrez Lugo, PhD, Marian E Ramirez, Marianela Aponte Cruz, Maribel V Juarbe, Marie A Fadden, Marilyn Santiago, Mark C Saale, Martinez, Mary E Farbman, PhD, Maryam Tabatabaie, Massoud Motamed, Matthew A Johnson, Matthew B Casale, Matthew R Maddox, Maxwell Van Tassell, PhD, Michael A Charles, Michael E Maselli, Michael L Casner, Michael R Klapal, Michael S Araneta, Michael Shanks, MS, Michelle Y Clark Stuart, Miguel A Martinez, Milva E Melendez, Milva Emelendez Perales, Monica Cburgos Garcia, Moraima J Ramos Valle, Mra M Barbosar, Mra Mcculloughj, Muralidhara B Gavini, PhD, Myriam M Sosa, Nadeem I Chaudhry, Nancy Rosado, Narong Chamkasem, PhD, Nebil A Oumer, Neil J Bonzagni, PhD MPH, Nicholas Obiri, PhD, Nikolay Spiridonov, Noreen Muniz, Noreen Muñiz, Nydia E Colon, Omotunde O Osunsanmi, Pablo Feliciano, Paraluman S Leonin, Parul M Patel, Patricia Fhughes Troost, Patrick C Klotzbuecher, Paul A Bonneau, Paul Z Balcer, Paula A Trost, Prabhu P Raju, Rachael A Moliver, Rafael Nevarez Nieves, Ramesh Potla, PhD, Ramon A Hernandez, Randy L Self, Rapti D Madurawe, Raquel Gonzalez, Raquel Gonzalez Rivera, Raymond T Oji, Reba A Gates, Rebeca M Melendez, Rebecca E Dombrowski, Rebecca Parrilla, Rebecca Rodriguez, Riley C Myers, PhD, Rita K Kabaso, Robert Darius, Robert J Doyle, Robert M Barbosa, Robert Q Jennings, Robert W Jennings, Rodney G Raiford, Rozelle G Smith, Russell J Glapion, Saleem A Akhtar, Samina S Khan, Sangeeta M Khurana, PhD, Sangeeta M Rataul, Sanket N Patel, Santos E Camara, Sarah Ibrahim, Sarah M Meng, Satheesh Thomas, Scott B Laufenberg, Scott T Ballard, Seema S Singh, Sena G Dissmeyer, Sharmista Chatterjee, Sharon K Thoma, PharmD, Shelby N Marler, Simone E Pitts, Sina Shojaee, Sonia M Monges, Sonia R Peterson, Sonya M Edmonds, Stephanie A Slater, MS, Stephen D Brown, Stephen J Mottola, Steven A Gonzales, Steven B Barber, Steven C Madzo, Steven Fong, MS, PhD, Steven P Donald, Susanna E Ford, Analyst, Susant Hadman, Tara L Greene, Teresa I Navas, Terri L Dodds, Thomas J Arista, Timothy T Kapsala, Timothy Wadkin, PhD, Tonia F Bernard, Torrance J Slayton, Uduak M Inokon, Unnee Ranjan, Uttaniti Limchumroon (Tom), Victor S Pacheco, Vilmary Negron, Walden H Lee, Wanda J Torres, Wayne D Mcgrath, Wayne E Seifert, Wendy G Tan, PhD, Yasamin Ameri, Ying Zhang, Yumi J Hiramine, Zachary L Stamm, Zhihao Qiu (Peter), PhD, Zhong Li, PhD

Vilmary Negron Rodriguez's Documents

Publish Date Document Type Title
December, 2017 FDA 483 Nipro Pharma Corporation - Form 483, 2017-12-15
February, 2016 FDA 483 MSN LABORATORIES PRIVATE LIMITED - Form 483, 2016-02-05
June, 2016 FDA 483 Patheon Puerto Rico, Inc. - Form 483, 2016-06-21
August, 2015 FDA 483 American Specialty Pharmacy - Form 483, 2015-08-05
April, 2018 FDA 483 Zydus Hospira Oncology Private Limited - Form 483, 2018-04-12
April, 2019 FDA 483 Suzhou Homesun Pharmaceutical Co., Ltd. - Form 483, 2019-04-12
July, 2019 FDA 483 Mary Kay, Inc - Form 483, 2019-07-19
November, 2015 EIR Galephar Pharmaceutical Research Inc - EIR, 2015-11-23
February, 2020 EIR MSD International GmbH (Puerto Rico Branch) LLC - EIR, 2020-02-26
December, 2018 EIR Sun Pharmaceutical Industries Limited - EIR, 2018-12-06
February, 2020 FDA 483 MSD International GmbH (Puerto Rico Branch) LLC - Form 483, 2020-02-26
February, 2017 FDA 483 Omega & Delta Co. Inc. - Form 483, 2017-02-07
March, 2018 FDA 483 Auro PR Inc. - Form 483, 2018-03-15
February, 2015 FDA 483 Baxter Healthcare Corporation - Form 483, 2015-02-06
February, 2015 EIR Baxter Healthcare Corporation - EIR, 2015-02-06
May, 2017 FDA 483 Amgen Manufacturing Ltd - Form 483, 2017-05-10
December, 2018 FDA 483 Intas Pharmaceuticals Limited - Form 483, 2018-12-14
January, 2016 EIR TYCHE INDUSTRIES LIMITED - EIR, 2016-01-29
May, 2015 FDA 483 Janssen Ortho LLC - Form 483, 2015-05-29
March, 2018 EIR Auro PR Inc. - EIR, 2018-03-15
March, 2016 FDA 483 Professional Arts Pharmacy - Form 483, 2016-03-23
August, 2018 FDA 483 Amgen Manufacturing Ltd - Form 483, 2018-08-06
April, 2019 FDA 483 Hangzhou Facecare Cosmetics Co., Ltd. - Form 483, 2019-04-05
November, 2015 FDA 483 Galephar Pharmaceutical Research Inc - Form 483, 2015-11-23
April, 2018 EIR Astral SteriTech Private Limited - EIR, 2018-04-03
October, 2016 FDA 483 Warner Chilcott Company, LLC - Form 483, 2016-10-03
December, 2015 FDA 483 NATIONAL VITAMIN COMPANY - Form 483, 2015-12-11

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more